Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial.
Ghazizadeh-Hashemi M, Ghajar A, Shalbafan MR, Ghazizadeh-Hashemi F, Afarideh M, Malekpour F, Ghaleiha A, Ardebili ME, Akhondzadeh S. Ghazizadeh-Hashemi M, et al. Among authors: shalbafan mr. J Affect Disord. 2018 May;232:127-133. doi: 10.1016/j.jad.2018.02.057. Epub 2018 Feb 21. J Affect Disord. 2018. PMID: 29486338 Clinical Trial.
Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial.
Esalatmanesh S, Abrishami Z, Zeinoddini A, Rahiminejad F, Sadeghi M, Najarzadegan MR, Shalbafan MR, Akhondzadeh S. Esalatmanesh S, et al. Among authors: shalbafan mr. Psychiatry Clin Neurosci. 2016 Nov;70(11):517-526. doi: 10.1111/pcn.12430. Epub 2016 Sep 29. Psychiatry Clin Neurosci. 2016. PMID: 27488081 Free article. Clinical Trial.
L-carnosine as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trial.
Ghajar A, Khoaie-Ardakani MR, Shahmoradi Z, Alavi AR, Afarideh M, Shalbafan MR, Ghazizadeh-Hashemi M, Akhondzadeh S. Ghajar A, et al. Among authors: shalbafan mr. Psychiatry Res. 2018 Apr;262:94-101. doi: 10.1016/j.psychres.2018.02.012. Epub 2018 Feb 3. Psychiatry Res. 2018. PMID: 29427913 Clinical Trial.
Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: A placebo-controlled, randomized clinical trial.
Shalbafan M, Malekpour F, Tadayon Najafabadi B, Ghamari K, Dastgheib SA, Mowla A, Shirazi E, Eftekhar Ardebili M, Ghazizadeh-Hashemi M, Akhondzadeh S. Shalbafan M, et al. J Psychopharmacol. 2019 Nov;33(11):1407-1414. doi: 10.1177/0269881119878177. Epub 2019 Oct 1. J Psychopharmacol. 2019. PMID: 31575326 Clinical Trial.
Comparison of vortioxetine and sertraline for treatment of major depressive disorder in elderly patients: A double-blind randomized trial.
Borhannejad F, Shariati B, Naderi S, Shalbafan M, Mortezaei A, Sahebolzamani E, Saeb A, Hosein Mortazavi S, Kamalzadeh L, Aqamolaei A, Ali Noorbala A, Namazi-Shabestari A, Akhondzadeh S. Borhannejad F, et al. J Clin Pharm Ther. 2020 Aug;45(4):804-811. doi: 10.1111/jcpt.13177. Epub 2020 May 18. J Clin Pharm Ther. 2020. PMID: 32420649 Clinical Trial.
Efficacy and safety of tipepidine as adjunctive therapy in major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial.
Hoobehfekr S, Moghaddam HS, Shalbafan M, Hashemi MG, Pirmoradi MM, Sakenian A, Poopak A, Kashefinejad S, Yarahmadi M, Akhondzadeh S. Hoobehfekr S, et al. Psychiatry Clin Neurosci. 2021 Feb;75(2):57-62. doi: 10.1111/pcn.13180. Epub 2020 Dec 19. Psychiatry Clin Neurosci. 2021. PMID: 33247483 Free article. Clinical Trial.
66 results